Biohaven Pharmaceutical
BHVN
$41.47
Share price
0.68%
Change (1 day)
191.84%
Change (1 year)
Categories
Biohaven Pharmaceutical (BHVN) - P/B ratio
P/B ratio as of May 2024 : 8.55
According to Biohaven Pharmaceutical
's latest financial reports the company has a price-to-book ratio of 8.55.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Biohaven Pharmaceutical - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 8.02 | 356.94% |
| 2022-12-31 | 1.76 | -98.16% |
| 2021-12-31 | 95.3 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.89 | -66.19% | 🇺🇸 USA |